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Abstract: Bisphosphonates, particularly those with N-substi-
tuted groups, are currently the most popular drugs for the
treatment of osteoporosis. However, their chemical struc-
tures are still rather simple and new synthetic methods are
needed to expand their molecular complexity and also im-
prove their specificity of action towards other targets as an-
ticancer, antibacterial, and antimalarial drugs. Herein, we
report a new class of potential antiresorption bisphospho-
nate drugs that have a pyrrolidine unit with different sub-
stituents, obtained through a simple dipolar cycloaddition
reaction between azomethine ylides and vinylidenebi-
sphosphonate derivatives as precursors. The methodology
led to the efficient preparation of a wide range of (1-methyl-
pyrrolidine-3,3-diyl)bis(phosphonic esters) derivatives with
different substituents in position 4.
Introduction
Because of their similarity to pyrophosphate, which is an im-
portant constituent of hydroxyapatite (HAP), the major constit-
uent of the mineral portion of bones, bisphosphonates (BPs)
are widely employed as drugs for the treatment of bone disor-
ders, such as hypocalcaemia and osteoporosis (Figure 1). By ex-
ploiting their specific bone-targeting properties,[1] this class of
molecules has been used for decades in medical treatments,[2]
although the correlation between their chemical structure and
biological activity is a still debated topic.[3, 4] The mineral por-
tion of bones is constantly formed by osteoblasts and redis-
solved by osteoclasts. The cellular activity of BPs is related to
their ability to inhibit specific enzymes, such as farnesyl di-
phosphate synthase (FPPS), geranylgeranyl diphosphate syn-
thase (GGPPS),[5, 6] and others,[7] present in osteoclasts, which
leads to their inactivation and eventual apoptosis.
In the chemical structure of BPs, the presence of a hydroxyl
group in position R1 (Figure 1) enhances the affinity for HAP
and the presence of N-substituted residues on R2 promotes
good performance in terms of antiresorptive efficiency, as
demonstrated, for example, by alendronic and zoledronic acid,
which are sold as drugs to combat osteoporosis (Figure 1).
High activity has been recently observed with a new class of
more-lipophilic BPs that lack the presence of the gem-OH
group in position R1 but have N-substituted cationic residues
with a long alkyl chain on R2. These molecules proved to be
extremely potent for osteoclast inhibition because they target-
ed both enzymes,[5] and they also have good prospects as anti-
cancer,[8] antibacterial, and antimalarial drugs.[9] The develop-
ment of new bisphosphonate drugs with N residues on R2 is
a highly desirable topic in the search for active drug candi-
dates with fewer side effects typical of this class of molecules,
such as inflammatory symptoms like fever, myalgia, arthralgias
and headache.
The synthesis of BPs differs if the target molecule has R1=
OH or H. In the first case, BPs are usually prepared by starting
from an acyl chloride[10] or a carboxylic acid.[11,12] Conversely,
BPs with R1=H are generally prepared by conjugate addition
of nucleophiles to vinylidenebisphosphonate tetraethylester
(VBP)[13] as a typical building block. Through this method, BPs
with heterocycles,[14] steroid conjugates,[15] or other functional
groups at the b position, such as thiols,[16] have been reported
in the literature. General classes of BPs have also been pre-
pared by metal-catalyzed addition of boronic acids and indoles
to VBP, as recently disclosed by our group.[17,18] Nitrogen-substi-
tuted BPs can be obtained with a multitude of functional
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Figure 1. Chemical structures of bisphosphonates, pyrophosphoric acid,
alendronic and zoledronic acids, and vinylidenebisphosphonate tetraethyl
ester.
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groups. For example, VBP acts as an efficient dienophile[19] for
cycloaddition reactions with dienes[20] and nitrones[21] to pro-
vide cyclic BPs and isoxazolidine-substituted BPs, respectively.
BPs with two alkyl derivatives in positions R1 and R2, or one
alkyl and one alkoxy derivative, could be obtained through the
formation of a new C@P bond by starting from monophospho-
nates.[22]
Results and Discussion
Herein, we take inspiration from examples of enantioselective
1,3-dipolar cycloadditions of azomethine ylides to electron-
poor alkenes,[23] and describe the synthesis of a large series of
substituted pyrrolidine that contain bisphosphonates obtained
through a 1,3-dipolar cycloaddition of azomethine ylides[24] to
VBP and other prochiral BP analogues as dipolarophiles. BPs
with similar structures have only marginally been reported in
the literature.[19,25]
Initially, the reaction between sarcosine, paraformaldehyde,
and VBP was investigated to observe the quantitative forma-
tion of the corresponding tetraethyl(1-methylpyrrolidine-3,3-
diyl)bisphosphonate derivative by heating the mixture at reflux
in toluene for 5 h (Scheme 1). The isolated product was charac-
terized by 1H, 31P, and 13C NMR spectroscopy and GC-MS (see
the Supporting Information) and showed a single resonance in
the 31P NMR spectrum at d=25.34 ppm due to the presence of
a plane of symmetry in the molecule.
Attempts were made to replace sarcosine with different
amino acids in the above reaction. Under experimental condi-
tions identical to those in Scheme 1, glycine led to the forma-
tion of the corresponding tetraethyl(pyrrolidine-3,3-diyl)bi-
sphosphonate derivative in quantitative yield, which was char-
acterized by a singlet at d=25.24 ppm in the 31P NMR spec-
trum (for full characterization, see the Supporting Information).
The use of other natural amino acids showed that the reaction
is highly influenced by the substituents: alanine and valine re-
sulted in significantly lower product formation (27 and 26%
31P NMR spectroscopic yield, respectively), whereas amino
acids with more branched and longer substituents (e.g. , phe-
nylalanine, proline, glutamic acid, and isovaline) showed no
evidence of pyrrolidine BP product formation, due to either
the limited solubility of the amino acid in the reaction medium
or the formation of numerous byproducts. It is worth noting
that when chiral amino acids were used, the corresponding
pyrrolidine BP products were characterized by the presence of
a stereocenter on the C2 carbon atom, as confirmed by the ob-
servation of two diastereotopic 31P resonances due to the
asymmetry of the molecules (e.g. , see the product from ala-
nine with 31P resonances at d=26.65 and 25.32 ppm, J=
14.6 Hz). However, despite starting from natural enantiopure
amino acids, the BP products were obtained as a racemic mix-
ture. This is due to the loss of the original stereocenter in the
decarboxylation step of the reaction, which leads to the forma-
tion of a 1,3-dipole that subsequently adds to the VBP.[26]
Substituted prochiral VBP precursors with aromatic units
were used in the same reaction in combination with different
amino acids and aldehydes to obtain multi-substituted pyrroli-
dine BP products (Table 1).
Initially, the phenyl and p-nitrophenyl precursors were used
as dipolarophiles in a 1,3-cycloaddition with glycine and form-
Table 1. 1,3-Cycloaddition between substituted aromatic VBP precursors,
different aldehydes, and amino acids.[a]
Entry R1 R2 R3 Isolated
yield [%]
1 H H 42
2 H H 48
3 H H 0
4 H H 0
5 H H 35
6 H H Me 27[b]
7 H Me 0
8 H Me 25[b]
9 H H 26[b]
10 H 0
11 H 0
[a] Reaction conditions: BP (0.65 mmol), amino acid (2.5 mmol), aldehyde
(6.5 mmol), toluene (25 mL), T=110 8C, t=18 h. [b] 31P NMR spectroscopy
yield.
Scheme 1. Synthesis of the 1-methylpyrrolidine-substituted BP by a reaction
between sarcosine, paraformaldehyde, and VBP and the mechanism of the
formation of the azomethine ylide and its cycloaddition to VBP.
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aldehyde, and showed a decrease in reaction yield compared
with simple VBP (Table 1, entries 1–2). Compared with simple
VBP, these substituted VBP precursors did not lead to the cor-
responding cycloaddition products in combination with valine
(Table 1, entries 9–11), and the reaction with alanine led to sim-
ilar product formation only with the p-nitrophenyl precursor
(Table 1, entries 6–8). Although the use of VBP precursors with
an electron-withdrawing group (EWG) generally improved reac-
tion yields, probably because they are better dipolarophiles,
the results reported in Table 1 generally indicate that steric hin-
drance plays a fundamental role in this reaction. In fact, several
attempts at cycloaddition made with the least bulky amino
acid, glycine, with different aromatic aldehydes occurred suc-
cessfully only with the highly electron-poor p-nitrobenzalde-
hyde in moderate yields, whereas the use of simple benzalde-
hyde or p-OMe-substituted benzaldehyde (Table 1, entries 3
and 4) resulted in a mixture of inseparable byproducts. In gen-
eral, the obtained products were difficult to purify by using
chromatography, probably because of the presence of residual
polar non-BP reagents used in the reaction.
Better results for product formation and purification were
obtained by using the N-substituted amino acid sarcosine as
the reagent, as reported in Table 2. In all cases, the correspond-
ing 1-methylpyrrolidine 4-substituted BPs were obtained in
good-to-moderate yields depending on the electronic and
steric properties of the prochiral VBP substrate. In fact, as re-
ported in Table 2, the reaction led to a 45% yield in the case
of the phenyl derivative (Table 2, entry 1), whereas the yields
were lower with more sterically demanding 2-naphthyl, bi-
phenyl, and o-bromophenyl derivatives (Table 2, entries 2, 3,
10), and no products were detected for the p-tBu aliphatic VBP
derivative (Table 2, entry 5). Similarly, with electron-donating
substituents on the aromatic moiety the reaction was less effi-
cient, as in the cases of tBu-, methoxy- or 3,4-dimethoxyphenyl
substituents (Table 2, entries 4, 6, 7). Only the p-nitrophenyl
precursor led to good product formation (68% yield), whereas
the p-fluorophenyl derivative showed only limited activity and
gave an 11% yield (Table 2, entries 9, 11).
The isolated products were characterized by using 1H, 31P,
and 13C NMR spectroscopy and GC-MS. In Figure 2, a typical
characterization for the binaphthyl BP derivative is reported.
The 31P{1H} NMR spectrum shows two distinct resonances for
the diastereotopic P atoms because of the presence of a stereo-
genic center in the molecule in position 4. The asymmetry of
the molecule was also revealed by the 1H NMR spectrum, in
which four different resonances for the terminal methyl units
of the ethoxy phosphonate groups were observed. Similar res-
onances were also observed for the other pyrrolidine BP-de-
rived products. Due to the proximity in chemical shift of the
pyrrolidine ring resonances and their extended reciprocal cou-
pling, the 1H NMR spectrum (Figure 2) shows numerous over-
lapped multiplets, as further shown in the 2D-NMR COSY spec-
tra (see the Supporting Information). 2D-NMR NOESY experi-
ments (see the Supporting Information) revealed intense NOE
cross-couplings between naphthyl protons and the Hb,c pro-
tons and also the Ha proton. Because of the facile pyramidal in-
version that occurs at the nitrogen atom of the five-membered
ring, these products are present as single racemic stereoiso-
mers and no syn–anti combinations are possible.[27]
We also investigated the use of aromatic aldehydes in place
of paraformaldehyde, together with sarcosine and VBP, to
Table 2. Synthesis of four-substituted 1-methylpyrrolidine-substituted BPs
by treatment of sarcosine with paraformaldehyde and prochiral VBPs.[a]
Entry R1 Isolated
yield [%]
1 45
2 30
3 21
4 33
5 0
6 20
7 34
8 0
9 11
10 7
11 68
[a] Reaction conditions: BP (0.65 mmol), amino acid (2.5 mmol), aldehyde
(6.5 mmol), toluene (25 mL), T=110 8C, t=18 h.
Figure 2. 1H NMR (bottom) and 31P{1H} NMR spectra (top) of the binaphthyl
BP derivative.
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obtain two- or five-substituted 1-methylpyrrolidine BP deriva-
tives (Table 3).
The reaction proved to be very sensitive to the electronic
properties of the aromatic aldehydes. In fact, benzaldehydes
and p-methoxybenzaldehyde did not show formation of the
desired product (Table 3, entries 1 and 2), whereas electron-
poor aldehydes, such as p-chlorobenzaldehyde, p-fluorobenzal-
dehyde, and p-nitrobenzaldehyde, provided the corresponding
products in 68, 64, and 73% yield, respectively (Table 3, en-
tries 3, 6, and 7). Even the position of the substituent group on
the ring affected the reaction and resulted in product forma-
tion only when the EWG was present in the para position
(Table 3, entries 3, 6, 7, 9). EWG substituents in the meta or
ortho positions led to moderate yields (Table 3, entry 10) or did
not react at all (Table 3, entries 4, 5, 8). Other aldehydes, such
as pentafluorobenzaldehyde (Table 3, entry 11) or 2-nitro-5-tri-
fluoromethylbenzaldehyde (Table 3, entry 12), even if electron
poor, did not provide the corresponding cycloadducts with
VBP.
An attempt to use a more elaborate carbonyl compound to
implement in the pyrrolidine ring was carried out by replacing
the aromatic aldehyde with isatin in the reaction with sarco-
sine and VBP. Isatin is a particularly attractive building block in
the synthesis of both natural products and heterocyclic and
noncyclic compounds in enantioselective reactions[28] and in
the preparation of biologically active spirooxindoles.[29] The re-
action between VBP, sarcosine, and isatin led to the formation
of the corresponding tetraethyl-1’-methyl-2-oxospiro[indolyn-
3,2’-pyrrolidin]-4’,4’diyldiphosphonate in 51% yield in 18 h
(Scheme 2).
Because the free bisphosphonic acid is the active form in
this class of drug candidates, as an example, tetraethyl-1-meth-
ylpyrrolidine-3,3-diyldiphosphonic ester was subjected to de-
protection of the ethyl ester moieties by treatment with
bromo trimethylsilane followed by hydrolysis with wet metha-
nol. The reaction proceeded nicely and provided the corre-
sponding water-soluble 1-methylpyrrolidine-3,3-diyldiphos-
phonic acid in >98% yield, which thus confirmed the stability
of the pyrrolidine BP units under the deprotection conditions.
Conclusion
We have reported an extensive investigation of the synthesis
of a new class of N-substituted heterocyclic BPs with pyrroli-
dines units, obtained by a 1,3-dipolar cycloaddition between
azomethine ylides and BP precursors. The methodology led to
the efficient preparation of a wide range of (1-methylpyrroli-
dine-3,3-diyl)bis(phosphonic acid) derivatives with different
substituents in position 4.
As general trends, we observed that the synthesis is more
productive with sarcosine than with other amino acids in
which the -NH2 group has no substituents. Similarly, better re-
sults were obtained by starting from BP precursors with either
low steric hindrance or electron-withdrawing substituents. The
same steric and electronic trends were observed with respect
to aldehydes or carbonyl compounds (isatin).
With the appropriate combination of aldehyde, prochiral BP,
and amino acid, this process allows us to obtain, with a fair
degree of flexibility, N-heterocyclic pyrrolidine bisphospho-
nates, similar to the highly active, commercial zoledronate,
with the possibility to modulate the structure (albeit with
some limitations), in particular in positions 1, 4, and 5 of the
amino BP ring.
Finally, as we have proved with the simplest homologue in
this series, the deprotection of the ethyl ester moieties with tri-
Table 3. Synthesis of five-substituted 1-methylpyrrolidine-substituted BPs.[a]
Entry R1 Isolated
yield [%][b]
1 0
2 0
3 73
4 0
5 0
6 64[b]
7 68[b]
8 0
9 80
10 18[b]
11 0
12 0
[a] Reaction conditions: BP (0.65 mmol), amino acid (2.5 mmol), aldehyde
(6.5 mmol), toluene (25 mL), T=110 8C, t=18 h. [b] 31P NMR spectroscopy
yield.
Scheme 2. Synthesis of tetraethyl-1’-methyl-2-oxospiro[indolyn-3,2’-pyrroli-
din]-4’,4’-diyldiphosphonate.
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methylsilyl bromide and subsequent hydrolysis occurs rather
simply, which provides high yields of the free bisphosphonic
acid in its biologically active form.
These molecules are currently under study to investigate
their biological and toxicological properties.
Experimental Section
Reagents and materials
All reagents employed were commercial products (from Aldrich)
and were used without purification. Vinylidenebisphosphonate tet-
raethyl ester (VBP) was prepared as reported in the literature.[13]
The prochiral vinylidenebisphosphonate tetraethyl esters were ob-
tained by treating methylene bisphosphonate with aromatic alde-
hydes.[30] All the synthetic work was carried out in air without the
exclusion of atmospheric oxygen. Solvents were dried and purified
according to standard methods. Flash chromatography was per-
formed on 230–400 mesh silica and thin-layer chromatography
was carried out on 20V20 cm ALUGRAMS Xtra SIL G/UV254 Ma-
cherey–Nagel.
1H, 31P{1H}, and 13C{1H} NMR spectra were recorded at 298 K by
using a Bruker Avance 300 spectrometer operated at 300.15, 121.5,
and 75 MHz, respectively, unless otherwise stated. d values [ppm]
are relative to Si(CH3)4 or 85% H3PO4. GC-MS analyses were per-
formed by using a GC Trace GC 2000 coupled with a quadrupole
MS Thermo Finnigan Trace MS and using the Full Scan method.
General procedure for the synthesis of pyrrolidine-substitut-
ed BPs
Bisphosphonate precursor (0.65 mmol) and toluene (25 mL) were
added to a round-bottomed flask equipped with a reflux condens-
er and a magnetic stir-bar, then amino acid (2.5 mmol, 4 equiv.)
and aldehyde (6.5 mmol, 10 equiv) were added. The mixture was
heated at reflux for 18 h with vigorous stirring. The solvent was re-
moved under reduced pressure and the reaction product was iso-
lated by using column chromatography (eluent: 1:1 acetone/ethyl
acetate) and characterized by using 1H, 31P, and 13C NMR spectros-
copy and GC-MS analysis.
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